中國春來(01969.HK)達成復牌指引 11月10日起復牌
格隆匯 11 月 9日丨中國春來(01969.HK)發佈公告,2020年3月23日,聯交所知會公司以下復牌指引:(a)對有關問題進行適當調查、公佈調查結果及採取適當的補救措施;(b)刊發所有未刊發財務業績並提出任何審核修改;(c)展示公司已制定足夠的內部控制及程序以遵守上市規則;及(d)向市場公佈公司一切重大資料。
公告稱,復牌指引已獲完全達成並令聯交所信納。應公司請求,股份已由2019年12月2日上午9時正起暫停於聯交所買賣。由於復牌指引已獲完全達成並令聯交所信納,公司已向聯交所申請股份由2020年11月10日上午9時正起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.